Effects of magnolol and honokiol derived from the traditional Chinese herbal remedies on gastrointestinal movement

World Journal of Gastroenterology

Volumn 11, Issue 28, 2005, Pages 4414-4418

  Zhang, Wei Wei ^a   Li, Yan ^a   Wang, Xue Qing ^a   Tian, Feng ^a   Cao, Hong ^b   Wang, Min Wei ^b   Sun, Qi Shi ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Gastrointestinal movement; Magnolol and honokiol

Indexed keywords

ACETYLCHOLINE; CALCIUM ION; CISAPRIDE; HONOKIOL; MAGNOLOL; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GASTROINTESTINAL DISEASE; GUINEA PIG; HERBAL MEDICINE; INTESTINE CONTRACTION; INTESTINE MOTILITY; MALE; MOUSE; MUSCLE CONTRACTILITY; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH EMPTYING; STOMACH FUNDUS;

EID: 23244452574     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i28.4414     Document Type: Article

References (15)

1. Wang JP, Ho TF, Chang LC, Chen CC. Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice. J Pharm Pharmacol 1995; 47: 857-860
2. Kuribara H, Kishi E, Hattori N, Yuzurihara M, Mjaruyama Y. Application of the elevated plus-maze test in mice for evaluation of the content of honokiol in water extracts of magnolia. Phytother Res 1999; 13: 593-596
3. Kuribara H, Stavinoha WB, Maruyama Y. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of magnolia bark, evaluated by an elevated plus-maze test in mice. J Pharm Pharmacol 1998; 50: 819-826
4. Kuribara H, Kishi E, Hattori N, Okada M, Maruyama Y. The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J Pharm Pharmacol 2000; 52: 1425-1429
5. Tsai SK, Huang SS, Hong CY. Myocardial protective effect of honokiol: an active component in Magnolia officinalis. Planta Med 1996; 62: 503-506
6. Francis J, Critchley D, Dourish CT, Cooper SJ. Comparisons between the effects of 5-HT and DL-fenfluramine on food intake and gastric emptying in the rat. Pharmacol Biochem Behav 1995; 50: 581-585
7. Bauer V, Holzer P, Ito Y. Role of extra- and intracellular calcium in the contractile action of agonists in the guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol 1991; 343: 58-64
8. Hunt RH. Evolving concepts in the pathophysiology of functional gastrointestinal disorder. J Clin Gastroenterol 2002; 35 (1 Suppl): S2-6
9. Tomi S, Plazinska M, Zagorowicz E, Ziolkowski B, Muszynski J. Gastric emptying disorders in diabetes mellitus. Pol Arch Med Wewn 2002; 108: 879-886
10. Hep A, Prasek J, Filipinsky J, Navratil P, David L, Dolina J, Dite P. Cisapride (Prepulsid) in the prevention of postoperative gastrointestinal atony. Rozhl Chir 1998; 77: 101-104
11. Quigley EM. Chronic Intestinal Pseudo-obstruction. Curr Treat Options Gastroenterol 1999; 2: 239-250
12. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001; 96: 689-696
13. Barone JA. Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother 1999; 33: 429-440
14. Drolet B, Rousseau G, Daleau P, Cardinal R, Turgeon J. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 2000; 102: 1883-1885
15. Layton D, Key C, Shakir SA. Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future. Pharmacoepidemiol Drug Saf 2003; 12: 31-40